Last updated on November 2017

A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (spinosad) for the Treatment of Scabies


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Dermatology | ATOPIC DERMATITIS | Family Practice | Healthy People 2010 | Seborrheic dermatitis
  • Age: Between 4 - 100 Years
  • Gender: Male or Female

-At least one household member must have active scabies infestation.

-Household members must be 6 or fever and all members must be willing to attend clinic visits.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.